Hypothesising here big time but...
If I were head of a big pharma, would I make an offer on Her-vaxx (lets say) which improves "Keytruda" ie less toxicity and potentially longer OS for advanced gastric cancer patients.. OR.. would I hold out and see what VAXINIA (CF33) can do and just elimate all lines of cancer all together..
I know what I'd do.
I'm wondering if the sheer enormity of CF33 detracts from our alternatives..
Not all BP's can buy or own the license to CF33, but at the same time if it is successful then there is no competition!
Hypothesising here big time but...If I were head of a big...
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.5¢ | $379.9K | 6.840M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1581916 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 680013 | 6 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |